CTIS2023-504480-17-00进行中（未招募）1 期
Clinical impact of pharmacokinetic monitoring of antibiotics in critically ill patients - IIBSP-TDM-2023-28
Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau0 个研究点目标入组 384 人开始时间: 2023年4月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 384
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients who are candidates for study entry must meet the following criteria (detailed in sections 5.1 Study Type and Design): - Age = 18 years. - Patients admitted to the Intensive Care Unit (ICU) who start treatment with the antibiotics under study and who meet the criteria for inclusion in the intervention or control group (detailed in sections 5.1 Study design). - Intervention group: initiation of treatment during the 48 hours prior to the plasma concentration determination (day and time set weekly). - Control group: start of treatment from the weekly time at which the plasma concentration of the intervention group is determined, until the same number of patients as the intervention group is reached that same week.
排除标准
- •Patients with a duration of antibiotic treatment < 72 hours, have an ICU stay < 48 hours or do not meet the inclusion criteria are excluded.
研究者
相似试验
招募中
3 期
Clinical outcomes of pharmacokinetic and pharmacodynamic meropenem dosing in critically ill patients with sepsis or septic shockClinical outcomes of pharmacokinetic and pharmacodynamic meropenem dosing in critically ill patients with sepsis or septic shock is not founded. In addition, Phra Phutthabat Hospital used meropenem in large quantities.meropenem, bacteria infection, mSOFA, sepsis, septic shockTCTR20220106001Silpakorn university92
已完成
不适用
Significance of therapeutic drug monitoring during enteral administration of vancomycin in critically ill patients: a retrospective observational studyClostridium difficile enteritis and methicillin resistant Staphylococcus aureus enteritisJPRN-UMIN000016955Chiba University Graduate School of Medicine
尚未招募
不适用
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous systemKCT0004878Woosung Pharma27
尚未招募
Unknown
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patientsTuberculosisACTRN12623001088639Western Sydney Local Health District30
进行中（未招募）
不适用
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA